Frank R. DeLeo
- Infectious Diseases top 0.02%
- Antimicrobial Resistance in Staphylococcus 103
- Clinical Biochemistry top 0.02%
- Bacterial Identification and Susceptibility Testing 25
- Microbiology top 0.05%
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 18
- Immunology top 0.2%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 47
- Immune Response and Inflammation 36
-
- Bacterial biofilms and quorum sensing 56
-
- Streptococcal Infections and Treatments 49
- Neonatal and Maternal Infections 16
- Co-authors
- Henry F. ChambersScott D. KobayashiMichaël OttoAdeline R. WhitneyJovanka M. VoyichNatalia MałachowaBarry N. KreiswirthKevin R. Braughton
- Journals
- Proceedings of the National Academy of Sciences (16 papers)The Lancet (2 papers)Journal of Biological Chemistry (8 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Frank R. DeLeo
187 papers receiving 22.7k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Infectious Diseases 12.0k
- Clinical Biochemistry 3.3k
- Microbiology 2.7k
- Molecular Medicine 2.0k
- Immunology 5.4k
Countries citing papers authored by Frank R. DeLeo
This map shows the geographic impact of Frank R. DeLeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank R. DeLeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank R. DeLeo more than expected).
Fields of papers citing papers by Frank R. DeLeo
This network shows the impact of papers produced by Frank R. DeLeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank R. DeLeo. The network helps show where Frank R. DeLeo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frank R. DeLeo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 3 | |
| 4 | 2014 | 156 | |
| 5 | 2014 | 1 | |
| 6 | Epithelial STAT3-induced antimicrobial protein, Reg3{gamma} is required for host defense against MRSA pneumonia in mice | 2012 | 1 |
| 7 | 2012 | 1 | |
| 8 | 2011 | 120 | |
| 9 | 2010 | 36 | |
| 10 | 2009 | 322 | |
| 11 | 2008 | 300 | |
| 12 | 2008 | 54 | |
| 13 | 2005 | 74 | |
| 14 | 2005 | 152 | |
| 15 | 2004 | 66 | |
| 16 | 2004 | 135 | |
| 17 | 2003 | 275 | |
| 18 | 2003 | 131 | |
| 19 | 2003 | 93 | |
| 20 | 2001 | 144 |
About Frank R. DeLeo
Frank R. DeLeo is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Medicine, having authored 189 papers that have together received 23.2k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (103 papers), Bacterial biofilms and quorum sensing (56 papers), Streptococcal Infections and Treatments (49 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (47 papers), Immune Response and Inflammation (36 papers), Bacterial Identification and Susceptibility Testing (25 papers), Antibiotic Resistance in Bacteria (18 papers) and Neonatal and Maternal Infections (16 papers). The work is most often cited by research in Infectious Diseases (12.0k citations), Clinical Biochemistry (3.3k citations) and Microbiology (2.7k citations). Frank R. DeLeo has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Henry F. Chambers, Scott D. Kobayashi, Michaël Otto, Adeline R. Whitney, Jovanka M. Voyich, Natalia Małachowa, Barry N. Kreiswirth, Kevin R. Braughton, James M. Musser and Mark T. Quinn. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.